Welcome to the international HTA database

Showing [23829 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	NIHR Health Technology Assessment programme	A systematic review of risk assessment strategies for populations at high risk of engaging in violent behaviour: update 2002-8
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Shilla and MAGEC systems for growing children with scoliosis: cost-effectiveness and clinical benefits
2013	Belgian Health Care Knowledge Centre (KCE)	Correction of refractive errors of the eye in adults – Part 1: Perceptions and experiences
2013	NIHR Health Technology Assessment programme	Lithium or an atypical antipsychotic drug in the management of treatment resistant depression: a systematic review and economic evaluation
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Medical specialist attendance in nursing homes]
2013	HAYES, Inc.	Ultrafiltration in congestive heart failure
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Probiotics for antibiotic-associated diarrhea, <i>clostridium difficile</i> infection and irritable bowel syndrome: a review of clinical evidence and safety
2013	Belgian Health Care Knowledge Centre (KCE)	Novel serum biomarkers for the prediction of cardiovascular risk
2013	NIHR Health Technology Assessment programme	A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Alpha IMS for blind retinitis pigmentosa
2013	NIHR Health Technology Assessment programme	A cluster randomised controlled trial and economic evaluation of a structured training programme for caregivers of inpatients after stroke: the TRACS trial
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The use of medical marijuana: guidelines and recommendations
2013	Belgian Health Care Knowledge Centre (KCE)	Quality indicators for the management of upper gastrointestinal cancer
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Methylnaltrexone bromide (Relistor) for opioid-induced constipation
2013	HAYES, Inc.	Autologous chondrocyte implantation of the knee
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Repetitive transcranial magnetic stimulation for specific patient populations: clinical and cost-effectiveness and safety
2013	Belgian Health Care Knowledge Centre (KCE)	Barriers and opportunities for the uptake of biosimilar medicines in Belgium
2013	HAYES, Inc.	Continuous passive motion for the treatment of joint contractures of the extremities
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Vedolizumab for ulcerative colitis – second or subsequent line
2013	HAYES, Inc.	Bilateral cochlear implantation in adults
2013	Belgian Health Care Knowledge Centre (KCE)	Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study
2013	HAYES, Inc.	Epidural steroid injections for low back pain and sciatica
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Vedolizumab for Crohn's disease – second or subsequent line
2013	HAYES, Inc.	Bilateral cochlear implantation in children
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Metal-ceramic versus all-ceramic dental crowns: a review of the clinical and cost-effectiveness
2013	Belgian Health Care Knowledge Centre (KCE)	Ankle sprains: diagnosis and therapy
2013	HAYES, Inc.	Laparoscopic CO2 laser ablation for endometriosis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ruxolitinib (Jakavi) for polycythaemia vera – second line
2013	HAYES, Inc.	Cognitive-behavioral therapy for the prevention of posttraumatic stress disorder in adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone for the treatment of chronic non-cancer pain: clinical effectiveness and guidelines
2013	HAYES, Inc.	Magnetic resonance elastography for detecting and staging liver fibrosis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for mastocytosis – second or subsequent line
2013	HAYES, Inc.	Endovascular repair of abdominal aortic aneurysms
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Metronidazole powder and cream for odour control in acute, chronic, and palliative wounds: clinical evidence and guidelines
2013	HAYES, Inc.	Mechanical stretching devices for the treatment of joint contractures of the extremities
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Monarch™ External Trigeminal Nerve Stimulation (eTNS™) System for depression
2013	HAYES, Inc.	Epidural steroid injections for cervical radiculopathy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neuromuscular occlusion concept-based diagnosis and treatment of tempromandibular joint disorders: a review of the clinical evidence
2013	HAYES, Inc.	Percutaneous left atrial appendage closure to reduce stroke risk in patients with atrial fibrillation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	COGNISION™ for neurological disorders, including dementia
2013	HAYES, Inc.	Fractional flow reserve testing for guiding Percutaneous Coronary Interventions (PCIs)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cardiac troponin for the diagnosis of acute coronary syndrome in the emergency department: a review of guidelines
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Prevention of fetal alcohol syndrome]
2013	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for the posttreatment management of cancer of the head and neck
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Monarch™ External Trigeminal Nerve Stimulation (eTNS™) System for epilepsy
2013	HAYES, Inc.	Intermittent pneumatic compression for peripheral arterial disease
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal method for driving assessment in older adults and in patients who have had a cerebrovascular accident: clinical evidence, cost-effectiveness, and guidelines
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013	NIHR Horizon Scanning Centre (NIHR HSC)	ExAblate® Neuro MR guided focused ultrasound for Parkinson's disease, essential tremor and neuropathic pain
2013	HAYES, Inc.	Lumbar total disc replacement for degenerative disc disease
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Preimplantation genetic screening (PGS) in patients undergoing high-complexity reproduction technologies]
2013	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of new-generation computed tomography scanners for imaging in coronary artery disease and congenital heart disease: Somatom Definition Flash, Aquilion ONE, Brilliance iCT and Discovery CT750 HD
2013	HAYES, Inc.	Simultaneous pancreas-kidney (SPK) transplantation in diabetic patients
2013	NIHR Horizon Scanning Centre (NIHR HSC)	NTrainer® for developing non-nutritive sucking in premature and newborn infants
2013	HAYES, Inc.	Nanoparticle albumin-bound paclitaxel for breast cancer
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Detection of sperm DNA fragmentation (TUNEL, SCSA, SCD, COMET) and use of annexin columns (MACS) in assisted reproduction treatments]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Treatments for localized prostate cancer: Radical prostatectomy versus brachytherapy. Systematic review of the literature and case series]
2013	HAYES, Inc.	Testosterone for low sexual desire in nonsurgically postmenopausal women
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Inspire® Upper Airway Stimulation System for obstructive sleep apnoea
2013	HAYES, Inc.	Nanoparticle albumin-bound paclitaxel for non-small cell lung cancer
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Whole exome sequencing for patients with intellectual disability/mental retardation or ASD]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficiency of peritoneal dialysis versus hemodialysis for the treatment of renal insufficiency]
2013	HAYES, Inc.	Transradial, transbrachial, and transulnar approaches for coronary angiography and intervention
2013	HAYES, Inc.	Angiotensin receptor 1 (AGTR1) c.*86A>C (1166A>C, A1166C) polymorphism testing for essential hypertension
2013	HAYES, Inc.	Neuroform microdelivery stent system for intracranial aneurysms
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Laparoscopic vertical sleeve gastrectomy vs. laparoscopic Roux-en Y gastric bypass for the treatment of obesity]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Efficacy and efficiency of psychological, psychiatric, sociomedical and complementary medical interventions for excessive crying in primary care services ("Schreiambulanzen") ]
2013	HAYES, Inc.	BRAF p.Val600Glu (V600E) testing to predict response to vemurafenib in malignant melanoma
2013	HAYES, Inc.	Pneumatic compression for prevention of deep vein thrombosis following knee surgery
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Tocilizumab for the treatment of rheumatoid arthritis]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Esteem® totally implantable hearing device for treatment of sensorineural hearing loss. Systematic review]
2013	NIHR Health Technology Assessment programme	Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review
2013	HAYES, Inc.	CHEK2-related susceptibility to breast cancer
2013	HAYES, Inc.	Roux-en-Y gastric bypass for gastroesophageal reflux disease in obese or severely obese patients
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Temozolomide for anaplastic oligodendroglioma]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for biotinidase deficiency]
2013	HAYES, Inc.	Citrin deficiency
2013	HAYES, Inc.	Salivary hormone testing for menopausal women
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiopurine-methyltransferase genotyping prior to thiopurine therapy]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of the Solitaire® flow restoration blood device]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013	HAYES, Inc.	Cystic Fibrosis Transmembrane Regulator (CFTR) testing for cystic fibrosis
2013	HAYES, Inc.	Spinal cord stimulation for relief of neuropathic pain
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Chromosomal microarrays for the etiologic diagnosis in patients with intellectual disability, developmental delay or autism spectrum]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Safety of natural therapies with direct impact on health: Acupuncture]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for classical galactosemia]
2013	HAYES, Inc.	DNA Polymerase Gamma (POLG)-related disorders
2013	HAYES, Inc.	Autosomal Dominant Hereditary Spastic Paraplegia (AD-HSP)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Risk-reducing surgery in BRCA1 or 2 mutation carriers]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, effectivity and efficiency of liquid cytology for cervical cancer screening and HPV infection diagnosis]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for tyrosemia type I]
2013	NIHR Health Technology Assessment programme	Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation
2013	HAYES, Inc.	Ehlers-Danlos Syndrome type IV (EDS IV)
2013	HAYES, Inc.	Autosomal Recessive Hereditary Spastic Paraplegia (AR-HSP)
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Use of antibiotic-loaded bone cement in primary hip and knee arthroplasty]
2013	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness of patient self-testing and patient self-management of oral anticoagulation with vitamin K antagonists]
2013	Canary Health Service	[Effectiveness and safety of biodegradable tracheobronchial prostheses]
2013	HAYES, Inc.	BRAF p.Val600Glu testing in papillary thyroid carcinoma